BrainGate2 for Tetraplegia and Movement Disorders

Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Tablet-01)

Recruiting N/A Interventional Study
Brainstem Stroke ALS Tetraplegia Spinal Cord Injuries Cervical Spinal Cord Injury
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 80
Sex
Any
Study type
Interventional
Purpose
Device Feasibility
Participants needed
6 (estimated)
Sponsor
Leigh R. Hochberg, MD, PhD. · Other
Who this trial is looking for

This trial is looking for people with severe movement disorders, such as tetraplegia, who want to use communication apps on tablets. Participants will be involved in a project that aims to help people move and communicate using their brain signals.

Are You a Good Fit for This Trial?

You may be able to join if

  • I have been diagnosed with a spinal cord injury or brainstem stroke.
  • I have complete or incomplete tetraplegia.
  • I live within a three-hour drive of the study site.
  • I have been enrolled in the BrainGate2 clinical trial before.

You may not be able to join if

  • I have a visual impairment that makes it difficult to see a computer screen.
  • I am on chronic oral or intravenous steroids.
  • I am on immunosuppressive therapy.
  • I have another serious disease that affects my ability to participate.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial
People with brainstem stroke, advanced amyotrophic lateral sclerosis (ALS, also known as Lou Gehrig's disease), or other disorders can become unable to move or speak despite being awake and alert. In this project, the investigators seek to further translate knowledge about interpreting brain signals related to movement, and to further develop an intracortical brain-computer interface (iBCI) that c…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Clinical diagnosis of spinal cord injury, brainstem stroke, muscular dystrophy, amyotrophic lateral sclerosis or other motor neuron disorders * Complete or incomplete tetraplegia (quadriplegia) * Must live within a three-hour drive of the Study site * Prior enrollment in Brain…
Contacts

Leigh R Hochberg, MD, Ph.D

617-724-9247

lhochberg@mgh.harvard.edu

CONTACT